HC Wainwright Reiterates Buy Rating on Zentalis Pharmaceuticals

HC Wainwright & Co. reiterated its Buy rating and $10.00 price target on Zentalis Pharmaceuticals. The target implies 369.5% upside from the Oct. 16 close of $2.13.